Advancements in clinical trials can pave the way to innovative treatment
Clinical trials and research aim to study new tests and treatments and evaluate the outcome of a study on...
Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 3: HER2
Human epidermal growth factor receptor 2 (HER2) is a member of the ERBB receptor tyrosine kinase family. It is...
Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 2: RET, NTRK1
RET RET (an abbreviation for Rearranged during Transfection) encodes a receptor tyrosine kinase for members of the glial cell...
Cancer may have started the fight but new research on oncology will open many doors and end the war
Cancer is a disease wherein a number of the body’s cells grow uncontrollably and spread to other body parts....
Infectious Disorders: In Light of Current Research
Infectious disease is defined as an illness that is transmitted from an infected source to a susceptible host, infected...
Genome Sequencing Project – Answers for Rare Disease
Some patients with a suspected rare genetic disease go without a diagnosis for years or even throughout a lifetime....
How Oncology Research in 2021 Shed Light on Therapy Area?
New research on oncology is creating new knowledge in several areas of therapy. This year is characterized by the...
Management of rare mutations in non-small cell lung cancer (NSCLC) – PART 1: MET, ROS1, and ALK
Why do we make a fuss about rare mutations in NSCLC? In 2015, they only made up about 1-2%...
How to know the status of acute lymphoblastic leukemia from epigenetic DNA modification?
Hematological cancers were among the first to be discovered to have abnormal demethylation status. Excretion of epigenetic DNA modification...
Colorectal Cancer and Gut Microbiome: Healthy Gut May Prevent It?
The gut microbiome plays several key roles in human health. Gut microbes assist us with the absorption of some...